vs
Side-by-side financial comparison of LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) and Zeo Energy Corp. (ZEO). Click either name above to swap in a different company.
LIFECORE BIOMEDICAL, INC. \DE\ is the larger business by last-quarter revenue ($31.1M vs $18.6M, roughly 1.7× Zeo Energy Corp.). Zeo Energy Corp. runs the higher net margin — -10.8% vs -32.1%, a 21.3% gap on every dollar of revenue. On growth, Zeo Energy Corp. posted the faster year-over-year revenue change (-0.4% vs -4.5%). Zeo Energy Corp. produced more free cash flow last quarter ($2.3M vs $25.0K). Over the past eight quarters, LIFECORE BIOMEDICAL, INC. \DE\'s revenue compounded faster (-0.1% CAGR vs -4.0%).
LIFECORE BIOMEDICAL, INC. is a biomedical firm focused on developing and manufacturing high-quality hyaluronic acid-based biomaterials. It operates three core segments: medical application products, pharmaceutical solutions, and personal care ingredients, with main markets spanning North America, Europe and the Asia-Pacific, supplying to leading medical device, pharmaceutical and cosmetic brand partners.
LFCR vs ZEO — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $31.1M | $18.6M |
| Net Profit | $-10.0M | $-2.0M |
| Gross Margin | 25.0% | — |
| Operating Margin | -9.9% | -11.8% |
| Net Margin | -32.1% | -10.8% |
| Revenue YoY | -4.5% | -0.4% |
| Net Profit YoY | -52.0% | -360.9% |
| EPS (diluted) | $-0.29 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $18.6M | ||
| Q3 25 | $31.1M | $23.9M | ||
| Q2 25 | — | $18.1M | ||
| Q1 25 | $35.2M | $8.8M | ||
| Q4 24 | $32.6M | $18.6M | ||
| Q3 24 | $24.7M | $19.7M | ||
| Q2 24 | — | $14.8M | ||
| Q1 24 | $35.7M | $20.1M |
| Q4 25 | — | $-2.0M | ||
| Q3 25 | $-10.0M | $-3.2M | ||
| Q2 25 | — | $-2.4M | ||
| Q1 25 | $-14.8M | $-6.4M | ||
| Q4 24 | $-6.6M | $-435.3K | ||
| Q3 24 | $-16.2M | $-424.3K | ||
| Q2 24 | — | $-277.8K | ||
| Q1 24 | $15.6M | $-1.5M |
| Q4 25 | — | — | ||
| Q3 25 | 25.0% | 57.9% | ||
| Q2 25 | — | 59.8% | ||
| Q1 25 | 28.0% | 99.3% | ||
| Q4 24 | 34.0% | — | ||
| Q3 24 | 21.8% | 50.2% | ||
| Q2 24 | — | 52.3% | ||
| Q1 24 | 33.3% | — |
| Q4 25 | — | -11.8% | ||
| Q3 25 | -9.9% | -8.3% | ||
| Q2 25 | — | -15.8% | ||
| Q1 25 | -25.7% | -153.8% | ||
| Q4 24 | -6.0% | -6.0% | ||
| Q3 24 | -46.9% | -15.2% | ||
| Q2 24 | — | -18.0% | ||
| Q1 24 | -2.5% | -20.1% |
| Q4 25 | — | -10.8% | ||
| Q3 25 | -32.1% | -13.5% | ||
| Q2 25 | — | -13.3% | ||
| Q1 25 | -42.0% | -72.4% | ||
| Q4 24 | -20.2% | -2.3% | ||
| Q3 24 | -65.7% | -2.2% | ||
| Q2 24 | — | -1.9% | ||
| Q1 24 | 43.8% | -7.6% |
| Q4 25 | — | — | ||
| Q3 25 | $-0.29 | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $-0.47 | $-0.48 | ||
| Q4 24 | $-0.25 | $1.11 | ||
| Q3 24 | $-0.53 | $-0.08 | ||
| Q2 24 | — | $0.03 | ||
| Q1 24 | $0.42 | $-1.54 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $18.9M | $6.1M |
| Total DebtLower is stronger | $136.0M | $79.1K |
| Stockholders' EquityBook value | $-10.5M | $5.3M |
| Total Assets | $235.2M | $56.9M |
| Debt / EquityLower = less leverage | — | 0.01× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $6.1M | ||
| Q3 25 | $18.9M | $3.9M | ||
| Q2 25 | — | $68.7K | ||
| Q1 25 | $5.4M | $2.9M | ||
| Q4 24 | $9.5M | $5.6M | ||
| Q3 24 | — | $4.3M | ||
| Q2 24 | — | $5.3M | ||
| Q1 24 | — | — |
| Q4 25 | — | $79.1K | ||
| Q3 25 | $136.0M | $84.6K | ||
| Q2 25 | — | $642.8K | ||
| Q1 25 | $124.9M | $715.4K | ||
| Q4 24 | $111.3M | $787.7K | ||
| Q3 24 | $106.3M | $858.6K | ||
| Q2 24 | — | $1.6M | ||
| Q1 24 | $97.1M | $748.8K |
| Q4 25 | — | $5.3M | ||
| Q3 25 | $-10.5M | $-1.7M | ||
| Q2 25 | — | $-59.4M | ||
| Q1 25 | $2.2M | $-23.1M | ||
| Q4 24 | $15.4M | $-88.9M | ||
| Q3 24 | $-3.9M | $-39.3M | ||
| Q2 24 | — | $-53.0M | ||
| Q1 24 | $17.7M | $-173.0M |
| Q4 25 | — | $56.9M | ||
| Q3 25 | $235.2M | $58.5M | ||
| Q2 25 | — | $46.2M | ||
| Q1 25 | $237.7M | $47.4M | ||
| Q4 24 | $255.4M | $61.0M | ||
| Q3 24 | $246.8M | $47.1M | ||
| Q2 24 | — | $49.1M | ||
| Q1 24 | $246.2M | $50.1M |
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 56.05× | — | ||
| Q4 24 | 7.20× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 5.49× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.8M | $2.4M |
| Free Cash FlowOCF − Capex | $25.0K | $2.3M |
| FCF MarginFCF / Revenue | 0.1% | 12.2% |
| Capex IntensityCapex / Revenue | 5.6% | 0.9% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-16.8M | $-9.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $2.4M | ||
| Q3 25 | $1.8M | $-6.6M | ||
| Q2 25 | — | $-2.3M | ||
| Q1 25 | $1.2M | $-2.3M | ||
| Q4 24 | $-6.1M | $3.5M | ||
| Q3 24 | $-613.0K | $162.2K | ||
| Q2 24 | — | $-2.2M | ||
| Q1 24 | $-1.4M | $-10.2M |
| Q4 25 | — | $2.3M | ||
| Q3 25 | $25.0K | $-6.8M | ||
| Q2 25 | — | $-2.7M | ||
| Q1 25 | $-4.3M | $-2.6M | ||
| Q4 24 | $-8.6M | $3.4M | ||
| Q3 24 | $-4.0M | $116.5K | ||
| Q2 24 | — | $-2.3M | ||
| Q1 24 | $-7.8M | $-10.4M |
| Q4 25 | — | 12.2% | ||
| Q3 25 | 0.1% | -28.6% | ||
| Q2 25 | — | -15.0% | ||
| Q1 25 | -12.1% | -30.0% | ||
| Q4 24 | -26.3% | 18.2% | ||
| Q3 24 | -16.3% | 0.6% | ||
| Q2 24 | — | -15.6% | ||
| Q1 24 | -21.8% | -51.5% |
| Q4 25 | — | 0.9% | ||
| Q3 25 | 5.6% | 1.0% | ||
| Q2 25 | — | 2.4% | ||
| Q1 25 | 15.5% | 4.2% | ||
| Q4 24 | 7.5% | 0.5% | ||
| Q3 24 | 13.9% | 0.2% | ||
| Q2 24 | — | 0.7% | ||
| Q1 24 | 17.8% | 1.1% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -0.09× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LFCR
| Transferred At Point In Time | $26.6M | 85% |
| Transferred Over Time | $4.5M | 15% |
ZEO
| Nonrelated Party | $18.1M | 98% |
| Related Party | $432.1K | 2% |
